2011-01-04 00:00:00,Celgene Corporation Files For Expanded Revlimid Approval In
2011-01-05 00:00:00,Celgene Corporation Comments On Long Term Call
2011-02-16 00:00:00,Celgene Corporation Announces Additional Billion Share Repurchase Program
2011-02-17 00:00:00,Celgene Celgene International Srl Announces Vidaza Receiving Positive Final Appraisal Determination from NICE for Use in National Health Service in England and Wales
2011-02-25 00:00:00,Elan plc and Celgene Corporation Enter into Settlement and License Agreement Related to ABRAXANE
2011-02-28 00:00:00,Celgene Corporation Announces FDA Grants Priority Review For ISTODAX sNDA For Treatment Of Progressive Or Relapsed PTCL
2011-04-05 00:00:00,ProMetic Life Sciences Enters Into Global Agreement With Celgene Corporation
2011-04-28 00:00:00,Celgene Corporation Raises FY 2011Guidance
2011-05-06 00:00:00,Celgene Corporation Announces Data From Multiple Phase III Studies
2011-10-27 00:00:00,Celgene Corporation Raises FY 2011 Guidance
2011-12-12 00:00:00,Celgene Celgene International Srl Announces Results From Comparative Analysis Of REVLIMID
2011-12-13 00:00:00,Celgene Celgene International Phase II Study Evaluates Clinical Benefit of Pomalidomide in Heavily Patients with Multiple Myeloma
2012-01-26 00:00:00,Celgene Corporation Confirms FY 2012 Outlook
2012-03-08 00:00:00,Celgene Corporation Completes Acquisition Of Avila Therapeutics
2012-04-09 00:00:00,AnaptysBio Announces Strategic Antibody Discovery Partnership With Celgene Corporation
2012-07-06 00:00:00,Celgene Corporation Mulls Human Genome Sciences Inc
2012-07-26 00:00:00,Celgene Corporation Raises FY 2012 EPS Reaffirms FY 2012 Revenue Guidance
2012-08-06 00:00:00,Celgene Corporation Announces Offering Of Senior Unsecured Notes
2012-08-07 00:00:00,Celgene Corporation Prices Billion of Senior Unsecured Notes
2012-08-13 00:00:00,Bionor Pharma Study of Combined with Celgene Revlimid in HIV Patients with Impaired Immune System Approved to Begin
2012-10-02 00:00:00,Celgene ABRAXANE Meets Primary Endpoint Of Survival In Phase III Metastatic Melanoma Study
2012-10-08 00:00:00,Celgene Corporation to Announce Third Quarter 2012 Results on October 25
2012-10-11 00:00:00,Boeing Expected to Produce Dividend Hike and 4 Stock Analyses Sparking
2012-10-12 00:00:00,DRH
2012-10-15 00:00:00,Celgene receives FDA approval for ABRAXANE to treat cell lung cancer
2012-10-16 00:00:00,Celgene and NPS Pharmaceuticals Shares Surge on Positive FDA News
2012-10-18 00:00:00,Recent Investment Ratings Updates for Celgene
